A smart insulin device under development could revolutionize how glucose levels are monitored in diabetes patients and deliver insulin doses when necessary.

Sanofi and Abbott are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their condition.

A new discovery at the Feinstein Institutes for Medical Research could have implications in the way diabetes is treated in the future.

For a while now there has been a heated debate surrounding hybrid and closed loop insulin systems.